Description
Retatrutide Disposable Pen — Opti-Gen Peptides
Laboratory accessory kit. For research use only.
Not for human use. Not for veterinary use.
Not licensed by the MHRA. Not a medicinal product.
Not a patient injection device.
Empty disposable pen body supplied in a fitted case with four 4 mm needle attachments, branded Opti-Gen Peptides. Sold only as a laboratory handling accessory. It does not contain retatrutide unless a separate RUO article is purchased and documented on its own COA.
Must not be used to administer substances to people or animals.
Identification
| Product name | Retatrutide Disposable Pen (accessory kit) |
| Supplier | Opti-Gen Peptides |
| Contents | 1 × empty disposable pen body; 4 × 4 mm needle attachments; fitted case |
| Peptide fill | None in this kit |
| Related research peptide (sold separately) | Retatrutide / LY3437943 (CAS 2381089-83-2) |
| Intended use | Laboratory accessory only |
Not semaglutide. Not tirzepatide. Not Mounjaro. Not Wegovy.
Quality / storage
Store dry as laboratory hardware. No assembly, priming, click-count, units or administration instructions on this page. Needles are not supplied for clinical or consumer injection.
Published research context (not product claims)
Retatrutide is a triple GIP / GLP-1 / glucagon receptor analogue. Receptor papers characterise triple-agonist pharmacology in experimental systems.
Clinical-development publications (including phase 2 work such as Jastreboff et al.) concern investigational drug programmes. Those papers are not authorisation to sell this pen kit as a medicine.
Wellness marketing of “triple agonists” as weight-loss products is not a claim for this accessory. There is no UK marketing authorisation.
UK notice
18+. Buyer confirms lawful laboratory use only and will not use or resell this kit for unauthorised human or animal administration.
Reviews
There are no reviews yet.